Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New vulnerability in "KL" KRAS subtype

Dec. 7, 2020

Data from phase II studies of VAL-083 in glioblastoma

Dec. 7, 2020

New IDO-1 inhibitors synthesized at Hutchison MediPharma

Dec. 7, 2020

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patent RET inhibitors

Dec. 7, 2020

Ascentawits Pharmaceuticals discovers AKR1C3-activatable DNA alkylating drugs

Dec. 7, 2020

New MAPK 1 inhibitors identified at Medshine Discovery

Dec. 7, 2020

Phase III study of masitinib in first-line pancreatic cancer with pain shows survival increase

Dec. 4, 2020

Henan Zhiwei Biomedicine, Henan Normal University present new BTK inhibitors

Dec. 4, 2020

New EGFR inhibitors discovered at Zhejiang University

Dec. 4, 2020

Sirnaomics to start phase I trial of STP-705 in liver cancer

Dec. 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...